Cenegermin

4 trials 1 recruiting SOphthalmology & ENT

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

11 Countries

Phase III

Phase II

Phase III: 1 Phase II: 3

Indications tested

Cerebral palsy 1 Persistent corneal epithelial defect 1 Dry eye 1

Sponsors using this IMP

Dompe' Farmaceutici S.p.A. 4

All trials

4 total

Proof-of-Concept Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of Intranasal Cenegermin in Adult Participants … Pending

2025-522692-29-00 Phase II 8 countries Dompe' Farmaceutici S.p.A.
An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Pending

2025-523443-35-00 Phase III 8 countries Dompe' Farmaceutici S.p.A.
Intranasal Cenegermin in Pediatric Participants with Spastic Cerebral Palsy. Recruiting

2025-522786-29-00 Phase II 1 country Dompe' Farmaceutici S.p.A.
A study to evaluate safety and efficacy of two different concentrations of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF… Ended

2023-507561-26-00 Phase II 1 country Dompe' Farmaceutici S.p.A.

Showing 1–4 of 4 trials

← All drugs A–Z